The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck

2020 ◽  
Vol 106 (1) ◽  
pp. 167-173 ◽  
Author(s):  
Sebastian Adeberg ◽  
Sati Akbaba ◽  
Kristin Lang ◽  
Thomas Held ◽  
Vivek Verma ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document